Sterling Capital Management LLC Akero Therapeutics, Inc. Call Options Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
176Shares Held
72.1MCall Options Held
178KPut Options Held
164K-
Wellington Management Group LLP Boston, MA7.9MShares$245 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$219 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$183 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$173 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$162 Million4.29% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.44B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...